B27.11 Cytomegaloviral mononucleosis with polyneuropathy

Name of the Condition

• Cytomegaloviral mononucleosis with polyneuropathy

Summary

Cytomegaloviral mononucleosis with polyneuropathy is a viral infection caused by the cytomegalovirus (CMV) that presents with symptoms of mononucleosis and involves damage to peripheral nerves. This condition combines the systemic effects of CMV infection with neurological manifestations, potentially leading to nerve-related symptoms. Most cases are managed with supportive care, though antiviral therapy may be considered in severe or immunocompromised individuals.

Causes

Cytomegaloviral mononucleosis with polyneuropathy is caused by infection with the cytomegalovirus, a member of the herpesvirus family. The virus spreads through bodily fluids such as saliva, blood, urine, semen, and breast milk. Transmission typically occurs through close contact with an infected person or exposure to contaminated materials. The polyneuropathy component may arise from direct viral invasion of peripheral nerves or an immune-mediated response to the infection.

Risk Factors

• Having a weakened immune system (e.g., due to HIV/AIDS, chemotherapy, or organ transplantation)
• Being in close contact with young children who shed the virus
• Working in healthcare or childcare settings
• Pre-existing neurological conditions that may increase susceptibility to nerve involvement

Symptoms

• Fever
• Fatigue
• Sore throat
• Swollen lymph nodes
• Muscle aches
• Numbness or tingling in the extremities
• Weakness in the arms or legs
• Difficulty with coordination or balance
• Pain or burning sensations in the affected areas

Diagnosis

Diagnosis typically involves a combination of clinical evaluation and laboratory testing. A physical exam may reveal swollen lymph nodes, an enlarged spleen, or signs of peripheral neuropathy. Blood tests can detect CMV antibodies or DNA, and a complete blood count may show atypical lymphocytes. Nerve conduction studies or electromyography may be used to assess nerve function, and imaging studies (e.g., MRI) may be considered if central nervous system involvement is suspected.

Treatment Options

• Supportive care, including rest, hydration, and over-the-counter pain relievers
• Antiviral medications such as ganciclovir or valganciclovir, primarily used in severe cases or in immunocompromised patients
• Physical therapy to manage neuropathy symptoms and improve mobility
• Pain management strategies for neuropathic pain, including medications like gabapentin or pregabalin

Prognosis and Follow-Up

Most individuals with cytomegaloviral mononucleosis with polyneuropathy recover fully with appropriate treatment, though recovery from neuropathy may take weeks to months. In immunocompromised patients, the condition may be more severe and require prolonged antiviral therapy. Follow-up appointments are important to monitor for symptom resolution, assess nerve function, and adjust treatment as needed. Regular monitoring of immune status is recommended for those with underlying immunosuppression.

Complications

• Persistent neuropathy or chronic pain
• Severe neurological impairment in immunocompromised individuals
• Organ involvement (e.g., hepatitis, pneumonia) in rare cases
• Recurrence of symptoms if the immune system remains compromised

Lifestyle & Prevention

• Practice good hygiene, including frequent handwashing, to reduce the risk of CMV transmission
• Avoid sharing personal items like utensils or toothbrushes
• Use barrier protection during sexual activity to minimize exposure to bodily fluids
• For immunocompromised individuals, avoid close contact with young children who may shed the virus
• Maintain a healthy lifestyle to support immune function, including balanced nutrition and regular exercise

When to Seek Professional Help

Seek medical attention if you experience:

• Severe or worsening neurological symptoms, such as significant weakness or loss of coordination
• High fever that does not improve with treatment
• Difficulty breathing or swallowing
• Signs of organ involvement, such as jaundice or chest pain
• Symptoms that persist or worsen after initial treatment

Tips for Medical Coders

When coding for cytomegaloviral mononucleosis with polyneuropathy (B27.11), ensure the documentation clearly indicates both the CMV infection and the presence of polyneuropathy. The code requires specificity to the neurological complication, so confirm that the medical record supports the diagnosis of nerve involvement. Avoid using this code for uncomplicated CMV mononucleosis or for polyneuropathy without a confirmed CMV infection. Documentation should include details of the neuropathy (e.g., symptoms, nerve function tests) to justify the code assignment.